Name: India, Pakistan and Cambodia Human Immunodeficiency Virus (HIV) Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)
Brand: DataM Intelligence
SKU: PH2862
Price: 3175 USD
Availability: InStock

India, Pakistan & Cambodia Human Immunodeficiency Virus Treatment Market 2024-2031

India, Pakistan and Cambodia Human Immunodeficiency Virus (HIV) Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

<h2>India, Pakistan &amp; Cambodia Human Immunodeficiency Virus (HIV) Treatment Market is segmented&nbsp;By Drug Type (Nucleoside Reverse Transcriptase Inhibitors (NRT&#39;s) (Emtriva, Epivir, Epzicom, Truvada, Biktarvy, Others), Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT&#39;s) (Edurant, Others), Protease Inhibitors (Aptivus, Kaletra, Lexiva, Norvir, Viracept, Others), Entry Inhibitors (Selzentry), HIV Integrase Strand Transfer Inhibitors (Isentress, Tivicay), Multi-class Combination Drugs (Atripla, Complera, Prezcobix/Prezista, Stribild, Genvoya, Odefsey, Symtuza, Triumeq, Descovy), Others),&nbsp;By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others),&nbsp;and By Region &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

&nbsp;

<h3>Report Overview</h3>

<blockquote>
The India, Pakistan &amp; Cambodia Human Immunodeficiency Virus (HIV) Treatment Market is expected to grow at a CAGR&nbsp;during the forecasting period (2024-2031).
</blockquote>

Human immunodeficiency virus (HIV) is a chronic and life-threatening disease, which can be transferred from one person to another through blood-to-blood and sexual contact.

HIV attacks immune cells known as CD-4 cells, making the body susceptible to infections and other diseases.

The rising prevalence of HIV disease has positively influenced the demand for HIV drugs. HIV drugs help to prevent the multiplication of HIV, thereby reducing the risk of its transmission.

The recent COVID-19 outbreak has impacted the growth of the HIV treatment market. HIV drugs are repurposed to treat COVID-19 infections. Several countries are evaluating and using antiretroviral drugs (for instance lopinavir boosted with ritonavir (LPV/r)), for treating coronavirus infection.

Some of the major players in the HIV treatment market are Merck &amp; Co., Inc., Bristol-Myers Squibb Company, Janssen (Johnson &amp; Johnson), F. Hoffmann-La Roche Ltd, Boehringer Ingelheim, GlaxoSmithKline plc, and Mylan Pharmaceutical.

<ol>
	<li>
	Methodology and Scope

	<ol>
		<li>
		Research Methodology
		</li>
		<li>
		Research Objective and Scope of the Report
		</li>
	</ol>
	</li>
	<li>
	Market Definition and Overview
	</li>
	<li>
	Executive Summary

	<ol>
		<li>
		Market Snippet by &nbsp;Drug Type
		</li>
		<li>
		Market Snippet by Distribution Channel
		</li>
		<li>
		Market Snippet by Country
		</li>
	</ol>
	</li>
	<li>
	Market Dynamics

	<ol>
		<li>
		Market Impacting Factors
		</li>
		<li>
		Drivers

		<ol>
			<li>
			XX
			</li>
			<li>
			XX
			</li>
		</ol>
		</li>
		<li>
		Restraints:

		<ol>
			<li>
			XX
			</li>
			<li>
			XX
			</li>
		</ol>
		</li>
		<li>
		Opportunity
		</li>
		<li>
		Impact Analysis
		</li>
	</ol>
	</li>
	<li>
	Industry Analysis

	<ol>
		<li>
		Porter&#39;s Five Forces Analysis
		</li>
		<li>
		Epidemiology
		</li>
		<li>
		Pipeline Analysis
		</li>
		<li>
		Regulatory Analysis
		</li>
		<li>
		Supply Chain Analysis
		</li>
		<li>
		Pricing Analysis
		</li>
		<li>
		Unmet Needs
		</li>
	</ol>
	</li>
	<li>
	COVID-19 Analysis

	<ol>
		<li>
		Analysis of Covid-19 on the Market
		</li>
		<li>
		Pricing Dynamics Amid Covid-19
		</li>
		<li>
		Demand-Supply Spectrum
		</li>
		<li>
		Government Initiatives Related to the Market During Pandemic
		</li>
		<li>
		Manufacturers Strategic Initiatives
		</li>
		<li>
		Conclusion
		</li>
	</ol>
	</li>
	<li>
	By Drug Type

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type Segment
			</li>
			<li>
			Market Attractiveness Index, By Drug Type Segment
			</li>
		</ol>
		</li>
		<li>
		Nucleoside Reverse Transcriptase Inhibitors (NRT&#39;s)*

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
			</li>
			<li>
			Emtriva
			</li>
			<li>
			Epivir
			</li>
			<li>
			Epzicom
			</li>
			<li>
			Truvada
			</li>
			<li>
			Biktarvy
			</li>
			<li>
			Others
			</li>
		</ol>
		</li>
		<li>
		Non- Nucleoside Reverse Transcriptase Inhibitors (NNRT&#39;s)

		<ol>
			<li>
			Edurant
			</li>
			<li>
			Others
			</li>
		</ol>
		</li>
		<li>
		Protease Inhibitors

		<ol>
			<li>
			Aptivus
			</li>
			<li>
			Kaletra
			</li>
			<li>
			Lexiva
			</li>
			<li>
			Norvir
			</li>
			<li>
			Viracept
			</li>
			<li>
			Others
			</li>
		</ol>
		</li>
		<li>
		Entry Inhibitors

		<ol>
			<li>
			Selzentry
			</li>
		</ol>
		</li>
		<li>
		HIV Integrase Strand Transfer Inhibitors

		<ol>
			<li>
			Isentress
			</li>
			<li>
			Tivicay
			</li>
		</ol>
		</li>
		<li>
		Multi-class Combination Drugs

		<ol>
			<li>
			Atripla
			</li>
			<li>
			Complera
			</li>
			<li>
			Prezcobix/Prezista
			</li>
			<li>
			Stribild
			</li>
			<li>
			Genvoya
			</li>
			<li>
			Odefsey
			</li>
			<li>
			Symtuza
			</li>
			<li>
			Triumeq
			</li>
			<li>
			Descovy
			</li>
		</ol>
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	By Distribution Channel

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel Segment
			</li>
			<li>
			Market Attractiveness Index, By Distribution Channel Segment
			</li>
		</ol>
		</li>
		<li>
		Hospital Pharmacies* *

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Market Size Analysis, US$ Million, 2019-2027 and Y-o-Y Growth Analysis (%), 2020-2027
			</li>
		</ol>
		</li>
		<li>
		Retail Pharmacies
		</li>
		<li>
		Online Pharmacies
		</li>
		<li>
		Others
		</li>
	</ol>
	</li>
	<li>
	By Country

	<ol>
		<li>
		Introduction

		<ol>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
			</li>
			<li>
			Market Attractiveness Index, By Country
			</li>
		</ol>
		</li>
		<li>
		India

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
			</li>
		</ol>
		</li>
		<li>
		Pakistan

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
			</li>
		</ol>
		</li>
		<li>
		Cambodia

		<ol>
			<li>
			Introduction
			</li>
			<li>
			Key Region-Specific Dynamics
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Drug Type
			</li>
			<li>
			Market Size Analysis, and Y-o-Y Growth Analysis (%), By Distribution Channel
			</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	Competitive Landscape

	<ol>
		<li>
		Competitive Scenario
		</li>
		<li>
		Market Positioning/Share Analysis
		</li>
		<li>
		Mergers and Acquisitions Analysis
		</li>
	</ol>
	</li>
	<li>
	Company Profiles

	<ol>
		<li>
		Merck &amp; Co. Inc.*

		<ol>
			<li>
			Company Overview
			</li>
			<li>
			Product Portfolio and Description
			</li>
			<li>
			Key Highlights
			</li>
			<li>
			Financial Overview
			</li>
		</ol>
		</li>
		<li>
		GlaxoSmithKline plc
		</li>
		<li>
		GlaxoSmithKline plc
		</li>
		<li>
		Sanofi
		</li>
		<li>
		Boehringer Ingelheim
		</li>
		<li>
		Janssen (Johnson &amp; Johnson)
		</li>
		<li>
		Pfizer
		</li>
		<li>
		Bristol-Myers Squibb Company
		</li>
		<li>
		Teva Pharmaceutical Industries Ltd.
		</li>
		<li>
		Mylan Pharmaceuticals
		</li>
		<li>
		Daiichi Sankyo
		</li>
		<li>
		Others&nbsp; (List Not Exhaustive)
		</li>
	</ol>
	</li>
	<li>
	DataM Intelligence

	<ol>
		<li>
		Appendix
		</li>
		<li>
		About Us and Services
		</li>
		<li>
		Contact Us
		</li>
	</ol>
	</li>
</ol>

India, Pakistan and Cambodia Human Immunodeficiency Virus (HIV) Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Severe Combined Immunodeficiency (SCID) Diagnosis Market Size, Share, Industry, Forecast and outlook (2023-2030)

Published: 2023 October 18

Starting from

Renal Insufficiency Market Size, Share, Industry, Forecast and Outlook (2024-2031)

Published: 2024 February 26

Starting from

Adrenal Insufficiency Market Size, Share, Industry, Forecast and Outlook (2023-2030)

Published: 2023 September 21

Starting from